MYGN
Income statement / Annual
Last year (2024), Myriad Genetics, Inc.'s total revenue was $837.60 M,
an increase of 11.21% from the previous year.
In 2024, Myriad Genetics, Inc.'s net income was -$127.30 M.
See Myriad Genetics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$837.60 M |
$753.20 M |
$678.40 M |
$690.60 M |
$557.00 M |
$638.60 M |
$851.10 M |
$772.60 M |
$771.40 M |
$753.80 M |
| Cost of Revenue |
$252.20 M
|
$236.20 M
|
$202.00 M
|
$197.60 M
|
$178.20 M
|
$186.10 M
|
$201.00 M
|
$177.20 M
|
$171.20 M
|
$157.30 M
|
| Gross Profit |
$585.40 M
|
$517.00 M
|
$476.40 M
|
$493.00 M
|
$378.80 M
|
$452.50 M
|
$650.10 M
|
$595.40 M
|
$600.20 M
|
$596.50 M
|
| Gross Profit Ratio |
0.7
|
0.69
|
0.7
|
0.71
|
0.68
|
0.71
|
0.76
|
0.77
|
0.78
|
0.79
|
| Research and Development Expenses |
$113.40 M
|
$88.70 M
|
$85.40 M
|
$81.90 M
|
$80.90 M
|
$77.20 M
|
$85.90 M
|
$70.80 M
|
$74.40 M
|
$70.60 M
|
| General & Administrative Expenses |
$275.90 M
|
$283.70 M
|
$247.90 M
|
$537.80 M
|
$0.00
|
$507.30 M
|
$556.60 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$284.10 M
|
$289.20 M
|
$266.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$560.00 M
|
$572.90 M
|
$514.70 M
|
$537.80 M
|
$500.70 M
|
$507.30 M
|
$556.60 M
|
$467.10 M
|
$476.40 M
|
$359.10 M
|
| Other Expenses |
$35.50 M
|
$112.80 M
|
$16.90 M
|
$63.80 M
|
$0.00
|
$99.70 M
|
$0.00
|
-$400.00 K
|
-$2.50 M
|
$1.20 M
|
| Operating Expenses |
$708.90 M
|
$774.40 M
|
$617.00 M
|
$683.50 M
|
$653.30 M
|
$684.20 M
|
$642.50 M
|
$537.90 M
|
$550.80 M
|
$429.70 M
|
| Cost And Expenses |
$961.10 M
|
$1.01 B
|
$819.00 M
|
$881.10 M
|
$831.50 M
|
$870.30 M
|
$843.50 M
|
$715.10 M
|
$722.00 M
|
$587.00 M
|
| Interest Income |
$1.70 M
|
$2.50 M
|
$2.60 M
|
$700.00 K
|
$9.20 M
|
$3.00 M
|
$3.20 M
|
$1.80 M
|
$1.20 M
|
$900.00 K
|
| Interest Expense |
$2.80 M
|
$2.90 M
|
$3.20 M
|
$6.60 M
|
$0.00
|
$10.80 M
|
$12.00 M
|
$3.20 M
|
$6.00 M
|
$300.00 K
|
| Depreciation & Amortization |
$61.20 M
|
$61.90 M
|
$52.70 M
|
$62.80 M
|
$71.40 M
|
$72.00 M
|
$73.00 M
|
$54.40 M
|
$48.30 M
|
$26.70 M
|
| EBITDA |
-$59.50 M |
-$197.40 M |
-$84.70 M |
$12.30 M |
-$123.40 M |
-$140.50 M |
$85.00 M |
$113.30 M |
$96.40 M |
$193.50 M |
| EBITDA Ratio |
-0.07
|
-0.26
|
-0.12
|
0.02
|
-0.22
|
-0.22
|
0.1
|
0.15
|
0.12
|
0.26
|
| Operating Income Ratio |
-0.15
|
-0.34
|
-0.21
|
-0.28
|
-0.35
|
-0.36
|
0.01
|
0.15
|
0.06
|
0.22
|
| Total Other Income/Expenses Net |
$0.00
|
-$4.80 M
|
$0.00
|
$133.40 M
|
-$88.90 M
|
$8.40 M
|
-$7.60 M
|
$60.80 M
|
-$1.70 M
|
$1.20 M
|
| Income Before Tax |
-$123.50 M
|
-$262.20 M
|
-$140.60 M
|
-$57.10 M
|
-$283.70 M
|
-$223.30 M
|
$0.00
|
$116.90 M
|
$42.90 M
|
$168.90 M
|
| Income Before Tax Ratio |
-0.15
|
-0.35
|
-0.21
|
-0.08
|
-0.51
|
-0.35
|
0
|
0.15
|
0.06
|
0.22
|
| Income Tax Expense |
$3.80 M
|
$1.10 M
|
-$28.60 M
|
-$29.90 M
|
$59.90 M
|
-$23.70 M
|
-$4.40 M
|
-$13.90 M
|
$21.30 M
|
$43.60 M
|
| Net Income |
-$127.30 M
|
-$263.30 M
|
-$112.00 M
|
-$27.20 M
|
-$223.70 M
|
-$199.50 M
|
$4.60 M
|
$131.00 M
|
$21.80 M
|
$125.30 M
|
| Net Income Ratio |
-0.15
|
-0.35
|
-0.17
|
-0.04
|
-0.4
|
-0.31
|
0.01
|
0.17
|
0.03
|
0.17
|
| EPS |
-1.41 |
-3.18 |
-1.39 |
-0.35 |
-2.99 |
-2.6850605652759 |
0.062585034013605 |
1.89 |
0.32 |
1.79 |
| EPS Diluted |
-1.41 |
-3.18 |
-1.39 |
-0.35 |
-2.99 |
-2.6850605652759 |
0.060526315789474 |
1.82 |
0.32 |
1.71 |
| Weighted Average Shares Out |
$90.60 M
|
$82.80 M
|
$80.58 M
|
$77.71 M
|
$74.70 M
|
$74.30 M
|
$73.50 M
|
$69.40 M
|
$68.30 M
|
$70.00 M
|
| Weighted Average Shares Out Diluted |
$90.60 M
|
$82.80 M
|
$80.60 M
|
$78.00 M
|
$74.78 M
|
$74.30 M
|
$76.00 M
|
$72.00 M
|
$68.80 M
|
$73.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
